Finished
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy
NCT06093971 · Yonsei University · Updated 12 Dec 2024
- What is being tested
- remimazolam; Propofol
- For
- Prostate Tumor
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years and older. About 112 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 17 Nov 2023, ends 22 Oct 2024. Registered 23 Oct 2023.
- Results
- None posted yet.
In the researchers' words
The investigators conduct a random assignment into either the remimazolam group or the propofol group. Depending on the group assignment, either remimazolam (0.2 mg/kg) or propofol (1.0 mg/kg) is administered. If necessary, additional doses of remimazolam (0.1 mg/kg) or propofol (0.5 mg/kg) are given. The standard anesthesia procedure of our institution is followed, and blood pressure data recorded during the surgery is analyzed (mean arterial pressure \<65mmHg is defined as hypotension).
Sites
- Yonsei University College of MedicineSeoul, South Korea